Adma Biologics (ADMA) Treasury Shares (2020 - 2025)

Adma Biologics' Treasury Shares history runs 1 years deep, the most recent figure standing at $32.1 million for Q4 2025.

• Quarterly Treasury Shares rose 432.25% year-over-year to $5.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $5.1 million (up 432.25% YoY) and the FY2025 annual result came in at $5.1 million, down 10.47% from the prior year.
• Treasury Shares was $5.1 million for Q4 2025 at Adma Biologics, down from $5.2 million in the prior quarter.
• Across five years, Treasury Shares topped out at $12.5 million in Q4 2023 and bottomed at $686133.0 in Q2 2021.
• A 5-year average of $4.9 million and a median of $4.9 million in 2023 frame the typical range for Treasury Shares.
• Annual changes were most pronounced in 2021 — Treasury Shares soared 1275.81% — and 2024, when it sank 92.27%.
• Adma Biologics' Treasury Shares stood at $4.5 million in 2021, then tumbled by 36.08% to $2.9 million in 2022, then jumped by 336.1% to $12.5 million in 2023, then sank by 92.27% to $966554.0 in 2024, then jumped by 432.25% to $5.1 million in 2025.
• Business Quant data shows ADMA's Treasury Shares at $32.1 million in Q4 2025, $8.0 million in Q3 2025, and $15.1 million in Q2 2025.